This study will establish a network of interactive asthma clinical research groups to
evaluate current therapies, new therapies, and management strategies for adult asthma.
This study will establish a network of interactive asthma clinical research groups to
evaluate current therapies, new therapies, and management strategies for adult asthma.
An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2003-08-01
The purpose of this study is to look at whether an investigational drug can treat the
breathing symptoms of RSV bronchiolitis in children 3 to 24 months of age.
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2002-04-01
The purpose of this study is to determine the protective effect of an approved medication on
asthma and allergic rhinitis (inflammation of the mucous membrane of the nose) upon exposure
to cats.
Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2004-07-01
The purpose of this study is to evaluate improved results of treatment for patients entering
an emergency department with asthma attacks when given an investigational IV administration
of an approved drug (MK-0476, montelukast sodium) in addition to approved standard treatment.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
